| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |